These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11699407)

  • 1. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
    Sharp JG; Bishop MR; Copple B; Greiner TC; Iversen PL; Jackson JD; Joshi SS; Benner EJ; Mann SL; Rao AK; Vose JM
    Leuk Lymphoma; 2001 Jul; 42(3):417-27. PubMed ID: 11699407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
    Bishop MR; Jackson JD; Tarantolo SR; O'Kane-Murphy B; Iversen PL; Bayever E; Joshi SM; Sharp JG; Pierson JL; Warkentin PI; Armitage JO; Kessinger A
    J Hematother; 1997 Oct; 6(5):441-6. PubMed ID: 9368180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
    Yu J; Batova A; Shao L; Carrera CJ; Yu AL
    Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.
    Attia SM; Alshahrani AY; Al-Hamamah MA; Attia MM; Saquib Q; Ahmad SF; Ansari MA; Nadeem A; Bakheet SA
    Toxicol Sci; 2017 Nov; 160(1):161-172. PubMed ID: 28973540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-dependent efficacy of idarubicin (Ida) and doxorubicin (Dox).
    Minderman H; Buscaglia MD; Rustum YM
    Leukemia; 1994 Aug; 8(8):1401-5. PubMed ID: 8057680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone.
    Abernethy DJ; Kleymenova EV; Rose J; Recio L; Faiola B
    Toxicol Sci; 2004 May; 79(1):82-9. PubMed ID: 14976336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
    Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis.
    Lomonosov M; Meziane el K; Ye H; Nelson DE; Randle SJ; Laman H
    PLoS One; 2011; 6(6):e21165. PubMed ID: 21695055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purging of human breast cancer cells from stem cell products with an adenovirus containing p53.
    Hirai M; Kelsey LS; Vaillancourt M; Maneval DC; Watanabe T; Talmadge JE
    Cancer Gene Ther; 2000 Feb; 7(2):197-206. PubMed ID: 10770627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences.
    Bayever E; Haines KM; Iversen PL; Ruddon RW; Pirruccello SJ; Mountjoy CP; Arneson MA; Smith LJ
    Leuk Lymphoma; 1994 Jan; 12(3-4):223-31. PubMed ID: 8167553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
    Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus.
    Wroblewski JM; Lay LT; Van Zant G; Phillips G; Seth P; Curiel D; Meeker TC
    Cancer Gene Ther; 1996; 3(4):257-64. PubMed ID: 8853551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line.
    Gewirtz DA; Randolph JK; Chawla J; Orr MS; Fornari FA
    Cancer Chemother Pharmacol; 1998; 41(5):361-9. PubMed ID: 9523731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.